Variant report
Variant | nsv968603 |
---|---|
Chromosome Location | chr9:21406645-21409787 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr9:21408084-21408246 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | ELK1 | chr9:21407420-21407466 | GM12878 | blood: | n/a | n/a |
3 | GATA3 | chr9:21408082-21408236 | SH-SY5Y | brain: | n/a | n/a |
4 | POLR2A | chr9:21407184-21407316 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | WRNIP1 | chr9:21409738-21409883 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:21409505-21409555 | IMR90 | lung: | fetal |
2 | chr9:21409505-21409555 | AG10803 | skin: | n/a |
3 | chr9:21409505-21409555 | HAEpiC | amniotic membrane: | n/a |
4 | chr9:21409505-21409555 | HEEpiC | esophagus: | n/a |
5 | chr9:21409505-21409555 | GM12891 | blood: | n/a |
6 | chr9:21409505-21409555 | HUVEC | blood vessel: | n/a |
7 | chr9:21409505-21409555 | HCPEpiC | choroid plexus: | n/a |
8 | chr9:21409505-21409555 | HIPEpiC | eye: | n/a |
9 | chr9:21409505-21409555 | CMK | blood: | n/a |
10 | chr9:21409505-21409555 | HPAEpiC | pulmonary alveolar: | n/a |
11 | chr9:21409505-21409555 | ProgFib | skin: | n/a |
12 | chr9:21409505-21409555 | HEK293 | kidney: | embryo |
13 | chr9:21409505-21409555 | K562 | blood: | n/a |
14 | chr9:21409505-21409555 | HMEC | breast: | n/a |
15 | chr9:21409505-21409555 | HNPCEpiC | eye: | n/a |
16 | chr9:21409505-21409555 | NB4 | blood: | n/a |
17 | chr9:21409505-21409555 | SKMC | muscle: | n/a |
18 | chr9:21409505-21409555 | Caco-2 | colon: | n/a |
19 | chr9:21409505-21409555 | SK-N-MC | brain: | n/a |
20 | chr9:21409505-21409555 | ovcar-3 | ovarian: | n/a |
21 | chr9:21409505-21409555 | SK-N-SH | brain: | n/a |
22 | chr9:21409505-21409555 | AoSMC | blood vessel: | n/a |
23 | chr9:21409505-21409555 | HCT-116 | colon: | n/a |
24 | chr9:21409505-21409555 | HRE | kidney: | n/a |
25 | chr9:21409505-21409555 | PANC-1 | pancreas: | n/a |
26 | chr9:21409505-21409555 | NT2-D1 | testis: | n/a |
27 | chr9:21409505-21409555 | HCM | heart: | n/a |
28 | chr9:21409505-21409555 | AG04449 | skin: | fetal |
29 | chr9:21409505-21409555 | GM12878 | blood: | n/a |
30 | chr9:21409505-21409555 | H1-hESC | embryonic stem cell: | embryo |
31 | chr9:21409505-21409555 | Hela-S3 | cervix: | n/a |
32 | chr9:21409505-21409555 | AG09309 | skin: | n/a |
33 | chr9:21409505-21409555 | HRPEpiC | eye: | n/a |
34 | chr9:21409505-21409555 | HCF | heart: | n/a |
35 | chr9:21409505-21409555 | HRCEpiC | kidney: | n/a |
36 | chr9:21409505-21409555 | GM19239 | blood: | n/a |
37 | chr9:21409505-21409555 | BE2_C | brain: | n/a |
38 | chr9:21409505-21409555 | LNCaP | prostate: | n/a |
39 | chr9:21409505-21409555 | NHDF-neo | bronchial: | n/a |
40 | chr9:21409505-21409555 | BJ | skin: | n/a |
41 | chr9:21409505-21409555 | PFSK-1 | brain: | n/a |
42 | chr9:21409505-21409555 | GM06990 | blood: | n/a |
43 | chr9:21409505-21409555 | PrEC | prostate: | n/a |
44 | chr9:21409505-21409555 | SK-N-SH_RA | brain: | n/a |
45 | chr9:21409505-21409555 | U87 | brain: | n/a |
46 | chr9:21409505-21409555 | NH-A | brain: | n/a |
47 | chr9:21409505-21409555 | HepG2 | liver: | n/a |
48 | chr9:21409505-21409555 | T-47D | breast: | n/a |
49 | chr9:21409505-21409555 | GM12892 | blood: | n/a |
50 | chr9:21409505-21409555 | MCF10A-Er-Src | breast: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
IFNA8 | TF binding region |
IFNA8 | CpG island |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76437655 | chr9:21406676-21406677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74853400 | chr9:21406681-21406682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs578044732 | chr9:21406728-21406729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75815701 | chr9:21406759-21406760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112782636 | chr9:21406781-21406782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188621180 | chr9:21406789-21406790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117451921 | chr9:21406847-21406848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192959378 | chr9:21406979-21406980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183923233 | chr9:21407055-21407056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368443550 | chr9:21407073-21407074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564057390 | chr9:21407090-21407091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532718530 | chr9:21407092-21407093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546571631 | chr9:21407238-21407239 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs1330322 | chr9:21407250-21407251 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs188609896 | chr9:21407251-21407252 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs548830694 | chr9:21407260-21407261 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs550904246 | chr9:21407315-21407316 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs4142400 | chr9:21407319-21407320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559282364 | chr9:21407366-21407367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1330321 | chr9:21407375-21407376 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs376304269 | chr9:21407406-21407407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565695384 | chr9:21407451-21407452 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs538454881 | chr9:21407471-21407472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs72701358 | chr9:21407510-21407511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571975401 | chr9:21407515-21407516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534273205 | chr9:21407519-21407520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183636706 | chr9:21407524-21407525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs28383784 | chr9:21407565-21407566 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs34345553 | chr9:21407595-21407596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567624282 | chr9:21408139-21408140 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs138535937 | chr9:21408172-21408173 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs556199566 | chr9:21408177-21408178 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs367668790 | chr9:21408182-21408183 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs141608009 | chr9:21408191-21408192 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs36016612 | chr9:21408199-21408200 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs115966176 | chr9:21408200-21408201 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs190326377 | chr9:21408232-21408233 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs191729261 | chr9:21409607-21409608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147319848 | chr9:21409631-21409632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552283876 | chr9:21409638-21409639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200979516 | chr9:21409674-21409675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537364943 | chr9:21409708-21409709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559740199 | chr9:21409758-21409759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371957734 | chr9:21409760-21409761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200547373 | chr9:21409761-21409762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376353525 | chr9:21409767-21409768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567440947 | chr9:21409771-21409772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20581869 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
Oral cancer | 22144094 | CNVD |
Lung cancer | 21569311 | CNVD |
Epilepsy | 20502679 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:21404400-21407600 | Weak transcription | Aorta | Aorta |
2 | chr9:21409600-21409800 | Enhancers | Primary monocytes fromperipheralblood | blood |